Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS

Curr Drug Deliv. 2018;15(7):1009-1019. doi: 10.2174/1567201815666171221125411.

Abstract

Objective: The aim of this study was to develop a novel W/O microemulsion for a natural extract of Wen-Luo-Tong (WLT) containing mainly icariin, hydroxysafflor yellow A (HSYA) and gallic acid to be applied to skin as a potential treatment for peripheral neuropathy.

Methods: The oil phase was selected on the basis of affinity with the surfactant and co-surfactant. Pseudo-ternary diagrams were constructed to optimize microemulsions and finally stability studies were performed on the selected formulations. Droplet sizes were analyzed by using a zetasizer and were found to be within the desired range. Selected microemulsions with acceptable viscosities, containing 5%, 8% and 10% of water extract solution, were used for in vitro skin penetration studies using Franz diffusion cells and excised rat skin. New LC-MS/MS and UPLC-Q-TOF/MS methods were employed for quantitative and qualitative analysis.

Results: The optimized formulation (ME-4) consisting of 10% (w/w) water extract solution, 60% isopropyl myristate, 30%(w/w) Smix: Propylene glycol (5:2) significantly increased the cumulative permeated amounts of HSYA, icariin and gallic acid compared with the water extract solution controls.

Conclusion: This novel formulation also increased the number of components penetrating rat skin. Ten components were detected in the Franz cell receptor solution using a UPLC-Q-TOF/MS system after the application of formulation ME-4 for 24h on the skin in vitro. However, only one component was detected after applying the control. Therefore, the microemulsion ME-4 was selected for future in vivo pharmacodynamic studies.

Keywords: LC-MS/MS; Microemulsion; UPLC-Q-TOF/MS; gallic acid; hydroxysafflor yellow A; icariin; transdermal delivery..

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Chalcone / administration & dosage
  • Chalcone / analogs & derivatives
  • Chalcone / chemistry
  • Chalcone / pharmacokinetics
  • Chromatography, High Pressure Liquid
  • Emulsions* / administration & dosage
  • Emulsions* / chemistry
  • Emulsions* / pharmacokinetics
  • Flavonoids / administration & dosage
  • Flavonoids / chemistry
  • Flavonoids / pharmacokinetics
  • Gallic Acid / administration & dosage
  • Gallic Acid / chemistry
  • Gallic Acid / pharmacokinetics
  • Male
  • Molecular Weight
  • Myristates / administration & dosage
  • Myristates / chemistry
  • Myristates / pharmacokinetics
  • Permeability
  • Propylene Glycol / administration & dosage
  • Propylene Glycol / chemistry
  • Propylene Glycol / pharmacokinetics
  • Quinones / administration & dosage
  • Quinones / chemistry
  • Quinones / pharmacokinetics
  • Rats, Sprague-Dawley
  • Skin / metabolism
  • Skin Absorption*
  • Surface-Active Agents / administration & dosage
  • Surface-Active Agents / chemistry
  • Surface-Active Agents / pharmacokinetics
  • Tandem Mass Spectrometry

Substances

  • Emulsions
  • Flavonoids
  • Myristates
  • Quinones
  • Surface-Active Agents
  • isopropyl myristate
  • hydroxysafflor yellow A
  • Chalcone
  • Gallic Acid
  • Propylene Glycol
  • icariin